Preferred Label : hypercholesterolemia, nos;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://www.has-sante.fr/jcms/p_3506440/fr/repatha-evolocumab-hypercholesterolemie
2024
false
false
false
France
evaluation of the transparency committee
repatha
Hypercholesterolemia
hypercholesterolemia
evolocumab
Evolocumab
evolocumab
hypercholesterolemia, nos

---
https://dumas.ccsd.cnrs.fr/dumas-01948467/document
2018
France
dissertations, academic
hypercholesterolemia, nos
health
Acrogeria
Stress fracture
hypercholesterolemia
primary prevention
Physicians
general practitioners
Hypercholesterolemia
principal
patient care management

---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=FR&Expert=477811
2017
false
false
false
France
French
scientific and technical information
hypercholesterolemia, nos
hypercholesterolemia
rare

---
https://www.revmed.ch/RMS/2016/RMS-N-508/Inhibiteurs-de-la-PCSK9-un-nouveau-traitement-pour-l-hypercholesterolemie
2016
false
false
false
Switzerland
French
journal article
therapeutics
new
hypercholesterolemia, nos
hypercholesterolemia

---
http://www.sfendocrino.org/_images/mediatheque/articles/pdf/Gueritee/Guer2012/2012bve.pdf
2012
France
scientific and technical information
phytosterols
hypercholesterolemia
endocrinology
hospitals, proprietary
hypercholesterolemia, nos

---
Nous contacter.
25/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.